Lilac Corp is a company that specializes in natural treatment against viruses and was founded in 2007. Lilac Corp has tens of thousands of people around the world taking their leading treatments Gene-Eden-VIR or Novirin daily. Lilac Corps two leading products Gene-Eden-VIR and Novirin are against HPV, Herpes and other viruses. What makes Lilac Corp unique is that many doctors prescribe Gene-Eden-VIR and Novirin to their patients. The reason is that all of Lilac Corps products are 100% natural, safe and effective. You can read customer testimonials by going to Lilac Corps website or searching on Google. All the products that Lilac Corp sells were developed using an Artificial Intelligence (AI) program called Computer Intuition. The basic principle of the Computer Intuition program is that every future event is preceded by clues, and that the key to realizing these events is identifying the future implication of these clues. The computer program investigates published scientific papers and assigns a rating to all the ideas found in the text. The rating can be interpreted as intuitive significance. The higher the intuitive significance of an idea, the more it hints on future findings or future discoveries. The program was designed to mimic the intuition of the greatest minds in science such as Newton, Einstein, Tesla and Edison, and was called Computer Intuition. When Lilac Corp was created, it licensed Gene-Eden-VIR, the first treatment developed using Computer Intuition. The Center for the Biology of Chronic Disease (CBCD) conducted clinical studies to test the Gene-Eden-VIR/Novirin treatments. As predicted by the developers of Computer Intuition, the clinical studies showed that the treatments are 100% natural, effective, have no side effects, and are better than the leading antiviral drugs available on the market. The results of these experiments were published in several leading peer-reviewed medical journals, such as Pharmacology and Pharmacy, and Drug Design, Development and Therapy. The published scientific papers that report the results of the clinical tests on Gene-Eden-VIR and Novirin can be found on PubMed the database of medical studies maintained by the United States National Library of Medicine (NLM) at the National Institutes of Health (NIH) and on the center’s website cbcd.net. Another treatment that was developed using AI is Nolopecia which was launched at the end of 2017. Nolopecia targets latent viruses that cause hair loss. Controlling latent viruses helps preserve normal levels of DHT and androgen receptor, which stimulates hair growth.
